EUVIMEDEUVIMED entdecken
Open Access

Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins

Lidia Strigari, Jazmin Schwarz, Tyler Bradshaw, Julia Brosch-Lenz, Geoffrey Currie, Georges El-Fakhri, Abhinav K Jha, Signe Mežinska, Neeta Pandit-Taskar, Emilie Roncali, Kuangyu Shi, Carlos Uribe und 4 weitere

Journal of Nuclear Medicine · 2025

DOI: 10.2967/jnumed.124.268186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2025. Verfasst von Lidia Strigari und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; lidia.strigari@aosp.bo.it. Hauptthemen laut MEDLINE: Nuclear Medicine, Precision Medicine, Radiopharmaceuticals, Theranostic Nanomedicine. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computational nuclear oncology for precision radiopharmaceutical therapy (RPT) is a new frontier for theranostic treatment personalization. A key strategy relies on the possibility to incorporate clinical, biomarker, image-based, and dosimetric information in theranostic digital twins (TDTs) of patients to move beyond a one-size-fits-all approach. The TDT framework enables treatment optimization by real-time monitoring of the real-world system, simulation of different treatment scenarios, and prediction of resulting treatment outcomes, as well as facilitating collaboration and knowledge sharing among health care professionals adopting a harmonized TDT. To this aim, the major social, ethical, and regulatory challenges related to TDT implementation and adoption have been analyzed.

Methods

The artificial intelligence-dosimetry working group of the Society of Nuclear Medicine and Molecular Imaging is actively proposing, motivating, and developing the field of computational nuclear oncology, a unified set of scientific principles and mathematic models that describe the hierarchy of etiologic mechanisms involved in RPT dose response. The major social, ethical, and regulatory challenges to realize TDTs have been highlighted from the literature and discussed within the working group, and possible solutions have been identified.

Results

This technology demands the implementation of advanced computational tools, harmonized and standardized collection of large real-time data, and modeling protocols to enable interoperability across institutions. However, current legislations limit data sharing despite TDTs' benefiting from such data. Although anonymizing data is often sufficient, ethical concerns may prevent sharing without patient consent. Approaches such as seeking ethical approval, adopting federated learning, and following guidelines can address this issue. Accurate and updated data input is crucial for reliable TDT output. Lack of reimbursement for data processing in treatment planning and verification poses an economic barrier. Ownership of TDTs, especially in interconnected systems, requires clear contracts to allocate liability. Complex contracts may hinder TDT implementation. Robust security measures are necessary to protect against data breaches. Cross-border data sharing complicates risk management without a global framework.

Conclusion

A mechanism-based TDT framework can guide the community toward personalized dosimetry-driven RPT by facilitating the information exchange necessary to identify robust prognostic or predictive dosimetry and biomarkers. Although the future is bright, we caution that care must be taken to ensure that TDT technology is implemented in a socially responsible manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear MedicinePrecision MedicineRadiopharmaceuticalsTheranostic NanomedicineHumans

Stichwörter der Autor:innen

digital twinsethicalregulatoryresearch methodssocioeconomictheranostic

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; lidia.strigari@aosp.bo.it.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Radiology, University of Wisconsin-Madison, Wisconsin.
  • Institute of Nuclear Medicine, Glen Burnie, Maryland.
  • School of Dentistry and Health Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
  • Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut.

Förderung

  • NCI NIH HHS

Zitieren

APA

Strigari, L., Schwarz, J., Bradshaw, T., Brosch-Lenz, J., Currie, G., El-Fakhri, G., Jha, A. K., Mežinska, S., Pandit-Taskar, N., Roncali, E., Shi, K., Uribe, C., Yusufaly, T., Zaidi, H., Rahmim, A., & Saboury, B. (2025). Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.268186

Vancouver

Strigari L, Schwarz J, Bradshaw T, Brosch-Lenz J, Currie G, El-Fakhri G, et al. Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins. Journal of Nuclear Medicine. 2025. doi:10.2967/jnumed.124.268186

BibTeX
@article{Strigari2025,
  author = {Strigari, Lidia and Schwarz, Jazmin and Bradshaw, Tyler and Brosch-Lenz, Julia and Currie, Geoffrey and El-Fakhri, Georges and Jha, Abhinav K and Mežinska, Signe and Pandit-Taskar, Neeta and Roncali, Emilie and Shi, Kuangyu and Uribe, Carlos and Yusufaly, Tahir and Zaidi, Habib and Rahmim, Arman and Saboury, Babak},
  title = {Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory, and Socioeconomic Dimensions of Theranostic Digital Twins},
  journal = {Journal of Nuclear Medicine},
  year = {2025},
  doi = {10.2967/jnumed.124.268186}
}
Kostenlos starten →